Trials / Active Not Recruiting
Active Not RecruitingNCT06497127
A Study in Patients With Mixed Dyslipidemia
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of Subcutaneously Administered BW-00112 in Patients With Mixed Dyslipidemia
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Shanghai Argo Biopharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 2 in Patients With Mixed Dyslipidemia
Detailed description
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel Study to Evaluate the Efficacy and Safety of Subcutaneously Administered BW-00112 in Patients with Mixed Dyslipidemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BW-00112 | BW-00112 or volume-matched placebo on Day 1 and Day 90 |
Timeline
- Start date
- 2024-02-28
- Primary completion
- 2026-06-30
- Completion
- 2028-03-30
- First posted
- 2024-07-11
- Last updated
- 2026-01-13
Locations
14 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06497127. Inclusion in this directory is not an endorsement.